Cover Image

Examining improvements to the regulation of medical technologies hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, May 2, 2017.

Main Author:	United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health,
Format:	eBook
Language:	English
Published:	Washington : U.S. Government Publishing Office, 2018.
Physical Description:	1 online resource (vi, 216 pages) : photographs.
Subjects:	United States. -- Food and Drug Administration -- Regulations. Medical instruments and apparatus -- Safety regulations -- United States -- Evaluation. Medical instruments and apparatus -- Regulations. Medical technology -- United States -- Cost control.
Online Access:	https://purl.fdlp.gov/GPO/gpo113051

Similar Items

Medical devices are current regulations doing enough for patients? : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, June 18, 2009
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Published: (2012)

The impact of medical device and drug regulation on innovation, jobs, and patients a local perspective : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, September 26, 2011
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Published: (2012)

FDA and the medical device industry : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, March 25 and June 3, 1992
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
Published: (1992)

Impact of medical device regulation on jobs and patients hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, February 17, 2011
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Published: (2011)

FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
Published: (1992)

Examining medical product manufacturer communications : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, July 12, 2017
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health,
Published: (2018)

H.R. 1346, the Medical Device Safety Act of 2009 hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, May 12, 2009
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Published: (2011)

Medical Device Regulatory Modernization Act of 1997 : report, together with additional views (to accompany H.R. 1710) (including cost estimate of the Congressional Budget Office)
by: United States. Congress. House. Committee on Commerce.
Published: (1997)

Medical device safety : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, on H.R. 3095 ... November 6, 1989 and July 17, 1990
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.
Published: (1990)

Examining FDA's Medical Device User Fee Program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 28, 2017
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health,
Published: (2018)

Reinventing regulation of drugs and medical devices
by: Clinton, Bill, 1946-
Published: (1995)

Medical devices : protecting patients and promoting innovation : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session ... November 15, 2011
by: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions,
Published: (2014)

Medical devices : protecting patients and promoting innovation : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session ... November 15, 2011
by: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions,
Published: (2014)

Medical device user fees : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session, on H.R. 4728, a bill to amend the Federal Food, Drug, and Cosmetic Act to authorize a device application fee, and for other purposes, July 14, 1994
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.
Published: (1994)

Regulating innovation : FDA's medical device approval process : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, U.S. House of Representatives, One Hundred Third Congress, first session, September 17, 1993
by: United States. Congress. House. Committee on Science, Space, and Technology. Subcommittee on Investigations and Oversight.
Published: (1993)

Medical Device User Fee Act of 1994 : report together with dissenting and additional views (to accompany H.R. 4864) (including cost estimate of the Congressional Budget Office)
by: United States. Congress. House. Committee on Energy and Commerce.
Published: (1994)

FDA management and enforcement : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, September 12, 1991
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
Published: (1992)

A delicate balance FDA and the reform of the medical device approval process : hearing before the Special Committee on Aging, United States Senate, One Hundred Twelfth Congress, first session, Washington, DC, April 13, 2011
by: United States. Congress. Senate. Special Committee on Aging.
Published: (2011)

Programs affecting safety and innovation in pediatric therapies hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 22, 2007
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Published: (2008)

Reusable medical equipment : continuing to examine VHA's sterile processing problems : hearing before the Subcommittee on Oversight and Investigations of the Committee on Veterans' Affairs, U.S. House of Representatives, One Hundred Fifteenth Congress, second session, Wednesday, September 5, 2018
by: United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Oversight and Investigations,
Published: (2019)

Food and Drug Administration Amendments Act of 2007 : report together with additional views (to accompany H.R. 2900) (including cost estimate of the Congressional Budget Office)
by: United States. Congress. House. Committee on Energy and Commerce.
Published: (2007)

Innovation in America opportunities and obstacles : hearing before the Subcommittee on Competitiveness, Innovation, and Export Promotion of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Eleventh Congress, second session, June 22, 2010
by: United States. Congress. Senate. Committee on Commerce, Science, and Transportation. Subcommittee on Competitiveness, Innovation, and Export Promotion.
Published: (2011)

FDA regulation of medical devices, including the status of breast implants : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 1, 1995
by: United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations,
Published: (1996)

Food, drug, cosmetic, and device enforcement amendments : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2597, a bill to amend the Federal Food, Drug, and Cosmetic Act to enhance the enforcement authority of the Food and Drug Administration, July 17, 1991
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.
Published: (1991)

FDA user fees 2012 : how innovation helps patients and jobs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, April 18, 2012
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health,
Published: (2013)

Medical Device User Fee and Modernization Act of 2002 : report (to accompany H.R. 3580)
by: United States. Congress. House. Committee on Energy and Commerce.
Published: (2002)

Reviewing FDA's implementation of FDASIA : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, November 15, 2013
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health,
Published: (2014)

Food and Drug enforcement standards for medical devices : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, September 14, 1995
by: United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations,
Published: (1997)

21st century cures : examining barriers to ongoing evidence development and communication : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, July 22, 2014
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health,
Published: (2015)

21st century cures : modernizing clinical trials : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, July 9, 2014
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health,
Published: (2015)

Food, Drug, Cosmetic, and Device Safety Amendments of 1992 : report together with dissenting views (to accompany H.R. 3642) (including cost estimate of the Congressional Budget Office)
by: United States. Congress. House. Committee on Energy and Commerce.
Published: (1992)

Medicare's competitive bidding program for durable medical equipment : implications for quality, cost and access : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, September 15, 2010
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health,
Published: (2013)

Reauthorization of the Medical Device User Fee and Modernization Act hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 16, 2007
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Published: (2008)

Medical device regulation : FDA-CDRH manufacturing, policies and regulation handbook
by: Wreh, Elijah.
Published: (2023)

Reinventing the regulation of cancer drugs : accelerating approval and expanding access
by: Clinton, Bill, 1946-
Published: (1996)

Is the FDA protecting consumers from dangerous off-label uses of medical drugs and devices? : fortieth report
by: United States. Congress. House. Committee on Government Operations.
Published: (1992)

Annual report of the Office of Science and Technology
by: Center for Devices and Radiological Health (U.S.). Office of Science and Technology.
Published: (1985)

Medical technology development and commercialization : hearing before the Subcommittee on Technology of the Committee on Science, U.S. House of Representatives, One Hundred Fourth Congress, first session, November 2, 1995
by: United States. Congress. House. Committee on Science. Subcommittee on Technology.
Published: (1995)

Food and Drug Administration employee performance standards for the timely review of medical product applications
by: Crosse, Marcia.
Published: (2012)

21st century technology for 21st century cures : joint hearing before the Subcommittee on Communications and Technology and the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, July 17, 2014
by: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Communications and Technology,
Published: (2015)